Skip to main content

Table 3 Regression coefficients for group differences at follow up

From: Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study

Rating Regression coeffiecient, B (95 % CI) Beta-cofficient SE Z P
Adjusted for pre-treatment rating scores
HTQ 0.07 (−0.09 – 0.22) 0.06 0.08 0.84 0.40
HSCL-25 0.07 (−0.10 – 0.23) 0.05 0.08 0.80 0.42
SCL 0.12 (−0.12 – 0.35) 0.07 0.12 1.03 0.31
SDS 2.31 (0.10 – 4.52) 0.16 1.13 2.05 0.04*
WHO-5 −5.79 (−12.05 – 0.46) −0.13 3.19 −1.82 0.07*
VAS 0.36 (−0.23 – 0.96) 0.08 0.30 1.20 0.23
SAS-SR 0.10 (−0.09 – 0.29) 0.07 0.10 1.06 0.29
CSS −0.35 (−2.18 - 1.47) −0.02 0.93 −0.35 0.71
GAF-F 1.22 (−1.03 – 3.47) 0.08 1.15 1.07 0.29
GAF-S 0.06 (−2.37 – 2.48) 0.00 1.24 0.04 0.96
HAM-D 0.19 (−1.94 – 2.33) 0.01 1.09 0.18 0.86
HAM-A −0.57 (−3.19 – 2.04) −0.03 1.34 −0.43 0.67
  1. Post-treatment differences between the venlafaxine and sertraline groups for the intention-to-treat sample
  2. CSS Crisis Support Scale, GAF Global Assessment of Functioning, HAM-A Hamilton Anxiety scale, HAM-D Hamilton Depression scale, HTQ Harvard Trauma Questionnaire, HSCL-25 Hopkins Symptom Checklist-25, SAS-SR Social Adjustment Scale - Self Report, SCL-90 Symptom Checklist-90, SDS Sheehan Disability scale, VAS Visual Analogue Scale, WHO-5 WHO-Five Well-being Index, B Regression coeffiecient, CI Confidence interval, Z Z-value SE Robust standard error of the regression coeffiecient, B, P P-value for the regression coeffiecient, B
  3. Bold: In favor of sertraline
  4. Italic: In favor of venlafaxine
  5. Bold and *: Statistically significant
  6. *: Marginally significant